Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

lysine/inflamação

O link é salvo na área de transferência
Página 1 a partir de 40 resultados

Topical vaginal use of lysine p-isobutylphenylpropionate in anti-inflammatory treatment

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
This invention relates to a new therapeutic use for lysine p-isobutylphenylpropionate. More particularly, the invention relates to the anti-inflammatory use of lysine p-isobutylphenylpropionate in topical gynecological therapy. Lysine p-isobutylphenylpropionate, also called hereinafter by its
The object of the present invention relates to a topical pharmaceutical composition in the form of foam containing as active ingredient a compound having antiinflammatory activity which belongs to the class of the arylpropionic acids. More particularly the arylpropionic acid contained in the

Anti-inflammatory peptides and use thereof

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION The present invention relates to peptides comprising lysine, alanine, leucine and valine, pharmaceutical compositions comprising same, and uses thereof for treating inflammatory conditions and allergy. BACKGROUND OF THE INVENTION Antimicrobial Peptides Lipopolysaccharides

Composition containing lysine as a nutritional supplement or treatment in the case of herpes

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
This application is a U.S. national phase application under 35 U.S.C. .sctn.371 of International Application No. PCT/EP2013/056145, filed Mar. 22, 2013, which claims priority to German Application No. DE 20 2012103733.5, filed Sep. 28, 2012, the disclosures of which is hereby incorporated by

Method of relieving pain and treating inflammatory conditions in warm-blooded animals

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND OF THE INVENTION Certain phenyl-alkanoic acids are known from the literature and some of them are said to possess valuable pharmacological activities, for example, an analgesic, anti-inflammatory or anti-pyretic action, whereas others are used clinically, for example, in the treatment of

Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF INVENTION The present invention relates to substances and compositions for the prevention and treatment of diseases or pathological states related to the degradation of the extracellular matrix, such as including but not limited to degenerative diseases, particularly arteriosclerosis,

Antipyretic and anti-inflammatory lys pro val compositions and method of use

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a new pharmaceutical composition useful for the treatment of pyrexia and inflammation. More particularly, this invention relates to a tripeptide sequence contained in alpha-Melanocyte Stimulating Hormone and ACTH which

Antipyretic and anti-inflammatory peptides

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
1. FIELD OF THE INVENTION This invention relates to a new pharmaceutical composition useful for the treatment of pyrexia and inflammation. More particularly, this invention relates to a tripeptide sequence contained in alpha-Melanocyte Stimulating Hormone and ACTH which has been identified as an

Peptides which stimulate the expression of the cytokines of inflammation and promote tissue regeneration

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION This invention concerns a new family of peptide molecules having the capacity especially of stimulating the expression of the cytokines of inflammation and promoting regeneration of tissues. The invention, thus, also pertains to pharmaceutical compositions containing at least

Use of GHL-Cu as a wound-healing and anti-inflammatory agent

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
TECHNICAL FIELD The present invention relates to the treatment of wounds in animals in general, and more specifically, to the use of a peptide having human superoxide dismutase activity, glycyl-L-hystidyl-L-lysine: copper(II), for enhancing the wound-healing process. BACKGROUND ART Mechanisms of

Labelled glutamine and lysine analogues

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
The present invention relates to a class of compounds useful in the diagnosis of sites of venous and arterial thrombosis, embolism or infection, pharmaceutical formulations containing them, their use in the diagnosis of disease and methods for their preparation. Prior approaches to thrombus imaging

Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION This invention relates to pharmaceutical compositions of the d,l- or l-lysine salt of R,S or S-ibuprofen having analgesic, anti-inflammatory and anti-pyretic activity. The invention further relates to a method of treating pain or inflammation or of reducing fever by

Drug for curing inflammatory and/or degenerative and/or atrophic mucous-membrane diseases

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
A preferred embodiment of this drug is further characterized by a proportion of vitamin A and/or vitamin B.sub.12 and/or folic acid. Another preferred embodiment of the drug as provided by the invention is characterized by a proportion of vitamin A and/or thymine (=a pyrimidine base). The drug in

Therapeutic agent for inflammatory bowel disease and TNF-.alpha. production inhibitor

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
TECHNICAL FIELD The present invention relates to an agent for treating or preventing an inflammatory bowel disease, comprising a particular amino acid(s). The present invention also relates to an agent for inhibiting TNF production, comprising a particular amino acid(s). BACKGROUND ART An

Compositions and methods for treating neoplasia, inflammatory disease and other disorders

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
INCORPORATION BY REFERENCE OF MATERIAL IN ASCII TEXT FILE This application incorporates by reference the Sequence Listing contained in the following ASCII text file being submitted concurrently herewith: a) File name: TDQ-10021_SEQLISTING.txt; created Feb. 1, 2018, 28 KB in size. BACKGROUND OF THE
Junte-se à nossa
página do facebook

O mais completo banco de dados de ervas medicinais apoiado pela ciência

  • Funciona em 55 idiomas
  • Curas herbais apoiadas pela ciência
  • Reconhecimento de ervas por imagem
  • Mapa GPS interativo - marcar ervas no local (em breve)
  • Leia publicações científicas relacionadas à sua pesquisa
  • Pesquise ervas medicinais por seus efeitos
  • Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas

Google Play badgeApp Store badge